Literature DB >> 307672

[Local reaction and neutralization test in smallpox vaccination after previous inoculation with MVA. Stickl's graduated vaccination (author's transl)].

F Hoffmann, H Poduschnik, K H Richter.   

Abstract

Of 200 first inoculations and 8 revaccinations, the sera were examined for content of neutralizing vaccine antibodies 3 weeks after the MVA graduated inoculation. In spite of imponderables which affect the failure rate in the "clinical trial", a positive result was obtained on first vaccination in 85%. In vaccinated children with a negative neutralization test a distinct booster effect was obtained with a "main vaccination" after about six months. The same effect was seen with revaccinations. For the time being inadequately controlled cerebral convulsive diseases, severe endogenous eczema, neurodermatitis, acute allergies, malignancies, immunosuppressive therapy, cortisole and intensive antirheumatic therapy and acute and purulent diseases must be considered as contraindications.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307672

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN: 0341-3098


  2 in total

1.  Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses.

Authors:  Sharon E Frey; Jack T Stapleton; Zuhair K Ballas; Wendy L Rasmussen; Thomas M Kaufman; Tammy P Blevins; Travis L Jensen; D Huw Davies; Magdalena Tary-Lehmann; Paul Chaplin; Heather Hill; Johannes B Goll
Journal:  J Infect Dis       Date:  2021-10-28       Impact factor: 7.759

2.  Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.

Authors:  Sharon E Frey; Anna Wald; Srilatha Edupuganti; Lisa A Jackson; Jack T Stapleton; Hana El Sahly; Samer S El-Kamary; Kathryn Edwards; Harry Keyserling; Patricia Winokur; Wendy Keitel; Heather Hill; Johannes B Goll; Edwin L Anderson; Irene L Graham; Christine Johnston; Mark Mulligan; Nadine Rouphael; Robert Atmar; Shital Patel; Wilbur Chen; Karen Kotloff; C Buddy Creech; Paul Chaplin; Robert B Belshe
Journal:  Vaccine       Date:  2015-07-02       Impact factor: 4.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.